title: Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children: A cross-sectional study.
abstract: Vaccination effectiveness is proven when the disease does not develop after a patient is exposed to the pathogen. In the case of rare diseases, vaccination effectiveness is assessed by monitoring specific antibody levels in the population. Such recurrent analyses allow the evaluation of vaccination programs. The primary schedule of diphtheria and tetanus vaccinations is similar in various countries, with differences mainly in the number and timing of booster doses. The aim of the study was to assess diphtheria and tetanus antibody concentrations in a population of healthy children.Diphtheria and tetanus antibody levels were analyzed in a group of 324 children aged 18 to 180 months. All children were vaccinated in accordance with the Polish vaccination schedule.Specific antibody concentrations greater than 0.1 IU/mL were considered protective against tetanus or diphtheria. Levels above 1.0 were considered to ensure long-term protection.Protective levels of diphtheria antibodies were found in 229 patients (70.46%), and of tetanus in 306 patients (94.15%). Statistically significant differences were found in tetanus antibody levels in different age groups. Mean concentrations and the percentage of children with high tetanus antibody titers increased with age. No similar correlation was found for diphtheria antibodies. High diphtheria antibody levels co-occurred in 72% of the children with high tetanus antibody levels; 95% of the children with low tetanus antibody levels had low levels of diphtheria antibodies.The percentage of children with protective diphtheria antibody levels is lower than that in the case of tetanus antibodies, both in Poland and abroad, but the high proportion of children without diphtheria protection in Poland is an exception. This is all the more puzzling when taking into account that Polish children are administered a total of 5 doses containing a high concentration of diphtheria toxoid, at intervals shorter than 5 years. The decrease in antibody titers occurring over time is a significant factor in vaccination program planning.Tetanus antibody concentrations were found to be high, but responses to the diphtheria and tetanus components were divergent. The percentage of children protected against diphtheria was significantly lower than protected against tetanus.
authors.affiliation: Family Medicine Department Department of Health Promotion, Poznan University of Medical Sciences Institute of Human Genetics Polish Academy of Sciences, Department of Molecular Pathology Department of Medical Diagnostic Dobra Department of Biostatistics, Poznan University of Medical Sciences Department of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
authors.forename: Ewelina
authors.initials: E
authors.lastname: Gowin
authors.forename: Jacek
authors.initials: J
authors.lastname: Wysocki
authors.forename: Ewelina
authors.initials: E
authors.lastname: Kałużna
authors.forename: Bogna
authors.initials: B
authors.lastname: Świątek-Kościelna
authors.forename: Joanna
authors.initials: J
authors.lastname: Wysocka-Leszczyńska
authors.forename: Michał
authors.initials: M
authors.lastname: Michalak
authors.forename: Danuta
authors.initials: D
authors.lastname: Januszkiewicz-Lewandowska
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood*; D000067576:Child Health; D002675:Child, Preschool; D003140:Communicable Disease Control / Q000379:methods; D003430:Cross-Sectional Studies; D004165:Diphtheria / Q000276:immunology* / Q000517:prevention & control; D004168:Diphtheria Toxoid / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D011044:Poland; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013742:Tetanus / Q000276:immunology* / Q000517:prevention & control; D013745:Tetanus Toxoid / Q000276:immunology*; D013997:Time Factors; D014611:Vaccination / Q000379:methods
chemical_list: D000907:Antibodies, Bacterial; D004168:Diphtheria Toxoid; D013745:Tetanus Toxoid